Evidence map›Paper›PMID 41971935›Full record

ArticleAME case reports2026

Zhenbo Hao, Chao Bian, Jie Yun, Zhijun Li

Abstract readCase Reports
In one paragraph

Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhenbo Hao *Inner Mongolia Clinical Medical College, Inner Mongolia Medical University, Hohhot, China.ORCID https://orcid.org/0009-0002-9340-2238
Chao Bian *Department of Radiotherapy, Inner Mongolia People's Hospital, Hohhot, China.
Jie YunDepartment of Radiotherapy, Inner Mongolia People's Hospital, Hohhot, China.
Zhijun LiInner Mongolia Clinical Medical College, Inner Mongolia Medical University, Hohhot, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Radiation pneumonitis (RP) is a common complication after thoracic radiotherapy, and corticosteroids are the mainstay of treatment. However, prolonged or high-dose steroid therapy predisposes patients to opportunistic infections that may closely mimic steroid-refractory RP, especially during the tapering phase. Distinguishing radiation-induced lung injury from superimposed fungal pneumonia in this setting is a major clinical challenge. Case Discription: We report a 55-year-old man with non-small cell lung cancer (NSCLC) who developed RP after surgery and adjuvant thoracic radiotherapy. His respiratory symptoms initially improved with high-dose intravenous methylprednisolone and antibacterial therapy. Early during steroid tapering, however, he experienced recurrent fever, worsening dyspnea, and new bilateral ground-glass opacities on chest computed tomography (CT) extending beyond the original radiation field. These findings raised concern for either RP flare or opportunistic infection. Bronchoscopy revealed congested bronchial mucosa with purulent secretions, and bronchoalveolar lavage (BAL) microscopy identified fungal spores. Conclusions: This case illustrates that

Indexed as

case reportopportunistic infectionpulmonary mycosis (PM)Radiation pneumonitis (RP)steroid therapy

Identifiers

PMID41971935
PMCPMC13062843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.